1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D9F773DFE4372BE6852572840056C58D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-scientific-publications-strategy-managing-reputation-clinical-trial-results-and-commercial-relevance?opendocument
18
19opendocument
2034.237.76.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance

Whitepaper Image

ID: BEB-32


Pages/Slides: 7


Published: Pre-2014


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS

Please click on
"Buy Now" to obtain the white paper on "Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance."
If you would like to purchase the full study this summary is based on click here.

Industries Profiled:
Pharmaceutical; Biotech; Chemical; Manufacturing; Health Care; Diagnostic


Companies Profiled:
Pfiizer; Vertex Pharmaceuticals; Genentech; Amgen; Biogen; GlaxoSmithKline; Merck; Bristol-Myers Squibb; Eli Lilly; AstraZeneca; Abbott; Shire